Morocco receives 4 million additional doses of AstraZeneca vaccine from India
London, Feb. 12, 2021 (AltAfrica)-Morocco received a second batch of 4 million doses of the AstraZeneca coronavirus vaccine on Thursday, having began Africa’s first national vaccination campaign two weeks ago, health ministry sources said.
The shipment of AstraZeneca vaccines, manufactured by India’s Serum Institute, arrived on a Royal Air Maroc flight in Casablanca.
“This new batch would enable a steady continuation of Morocco’s national vaccination campaign,” said Said Afif, a member of the health ministry’s scientific committee.
The latest batch of AstraZeneca vaccines follows 2 million doses received last month and 500,000 doses of the COVID-19 vaccine developed by Sinopharm.
By Thursday Morocco had vaccinated 855,318 Moroccan citizens and residents against COVID-19 and reported 476,689 coronavirus infections and 8,436 deaths.
The country has ordered enough vaccine for 33 million people and aims to inoculate 80% of the population.
The national vaccination campaign against the coronavirus seeks to inoculate at least 33 million Moroccans in order to achieve collective immunity.
The country continues to record new cases of COVID-19 daily.
Health authorities recorded 471 new COVID-19 cases in the last 24 hours.
The figures bring the total number of Morocco’s confirmed COVID-19 cases to 477,160.
In the past 24 hours, the health ministry also announced 574 new recoveries from COVID-19 and four coronavirus-related deaths.
The total number of recovered COVID-19 patients in Morocco currently stands at 457,325, marking a 95.8% national recovery rate. The number of deaths, meanwhile, reached 8,440, maintaining a national fatality rate of 1.8%.
Morocco now counts 11,395 active COVID-19 cases, including 530 carriers in severe or critical condition.